Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Tarlock

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|December 23, 2017
Donor derived T-cell large granular lymphocyte leukemia after cord blood transplant for pediatric T-cell lymphoblastic leukemiaTyler G Ketterl, David Wu, Jonathan R Fromm, et al.
Pediatric Blood & Cancer|September 11, 2025
A Case of Blinatumomab Efficacy in RAM Immunophenotype/CBFA2T3::GLIS2 Fusion AMLMaya Ball-Burack, Andrew Menssen, Lisa Eidenschink Brodersen, et al.
Pediatric Blood & Cancer|September 14, 2023
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712Katherine Tarlock, Xiaowei Liu, Charles G Minard, et al.
Blood|March 19, 2020
Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemiaKatherine Tarlock, Todd Alonzo, Yi-Cheng Wang, et al.
Cancers|May 28, 2025
Disease Burden at the Time of Transplantation Is a Primary Predictor of Outcomes in Pediatric MDS: A Single-Center ExperienceAnn Dahlberg, Phil Stevenson, Neel S Bhatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2015
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Robert B Gerbing, et al.
British Journal of Haematology|March 26, 2014
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Pilar Palomo Moraleda, et al.
Transplantation and Cellular Therapy|June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular TherapyKatherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
The Lancet. Haematology|September 5, 2021
Haematological malignancies in sub-Saharan Africa: east Africa as an example for improving careClement D Okello, Nixon Niyonzima, Marta Ferraresso, et al.
The American Journal of Tropical Medicine and Hygiene|July 27, 2022
Case Report: The First Case Report of Visceral Leishmaniasis in CambodiaSam Lyvannak, Korb Sreynich, Sing Heng, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|December 23, 2017
Donor derived T-cell large granular lymphocyte leukemia after cord blood transplant for pediatric T-cell lymphoblastic leukemiaTyler G Ketterl, David Wu, Jonathan R Fromm, et al.
Pediatric Blood & Cancer|September 11, 2025
A Case of Blinatumomab Efficacy in RAM Immunophenotype/CBFA2T3::GLIS2 Fusion AMLMaya Ball-Burack, Andrew Menssen, Lisa Eidenschink Brodersen, et al.
Pediatric Blood & Cancer|September 14, 2023
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712Katherine Tarlock, Xiaowei Liu, Charles G Minard, et al.
Blood|March 19, 2020
Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemiaKatherine Tarlock, Todd Alonzo, Yi-Cheng Wang, et al.
Cancers|May 28, 2025
Disease Burden at the Time of Transplantation Is a Primary Predictor of Outcomes in Pediatric MDS: A Single-Center ExperienceAnn Dahlberg, Phil Stevenson, Neel S Bhatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2015
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Robert B Gerbing, et al.
British Journal of Haematology|March 26, 2014
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Pilar Palomo Moraleda, et al.
Transplantation and Cellular Therapy|June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular TherapyKatherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
The Lancet. Haematology|September 5, 2021
Haematological malignancies in sub-Saharan Africa: east Africa as an example for improving careClement D Okello, Nixon Niyonzima, Marta Ferraresso, et al.
The American Journal of Tropical Medicine and Hygiene|July 27, 2022
Case Report: The First Case Report of Visceral Leishmaniasis in CambodiaSam Lyvannak, Korb Sreynich, Sing Heng, et al.
Pageof 5